FDAnews
www.fdanews.com/articles/68625-amersin-subsidiary-secures-new-ribavirin-contract

Amersin Subsidiary Secures New Ribavirin Contract

February 10, 2005

Hubei Tongji Benda Ebei Pharmaceutical Co., a subsidiary of Amersin Life Sciences, has entered into a sales contract with Zhangjiang Pharmacy Co. to supply 1.5 million doses of Ribavirin in injection form. Zhangjiang Pharmacy is a pharmaceutical distribution company specializing in South East Asia markets, including Thailand, Vietnam and Burma. Many of its customers, especially those from Vietnam and Thailand, are building inventories of antiviral products following recently confirmed human cases of bird flu (H5N1).
Big News Network